CROI 2018-Affiliated HIV/TB Research Frontiers Meeting

WHO organized an HIV/TB Research Frontiers meeting entitled "Short-Course Rifamycin Regimens and Dolutegravir: Silver Bullets?", in conjunction with the Conference on Retroviruses and Opportunistic Infections (CROI 2018) on March 4, 2018. The meeting was chaired by Richard Chaisson of Johns Hopkins Medicine, and Constance Benson of the University of California, San Diego. The main aim of the meeting was to stimulate high level scientific debate around the opportunities, challenges, and scientific research implications posed by the latest short-course rifamycin-based TB preventive regimens in the context of the latest generation of antiretroviral drugs such as Dolutegravir.